These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26209586)

  • 1. Optic neuropathy in methylmalonic acidemia and propionic acidemia.
    Martinez Alvarez L; Jameson E; Parry NR; Lloyd C; Ashworth JL
    Br J Ophthalmol; 2016 Jan; 100(1):98-104. PubMed ID: 26209586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late onset optic neuropathy in methylmalonic and propionic acidemia.
    Williams ZR; Hurley PE; Altiparmak UE; Feldon SE; Arnold GL; Eggenberger E; Mejico LJ
    Am J Ophthalmol; 2009 May; 147(5):929-33. PubMed ID: 19243738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyolysis in organic acidemia patients manifesting with metabolic decompensation.
    Kido J; Matsumoto S; Sawada T; Endo F; Nakamura K
    Hemodial Int; 2019 Oct; 23(4):E115-E119. PubMed ID: 31476111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optic neuropathy in classical methylmalonic acidemia.
    AlOwain M; Khalifa OA; Al Sahlawi Z; Hussein MH; Sulaiman RA; Al-Sayed M; Rahbeeni Z; Al-Hassnan Z; Al-Zaidan H; Nezzar H; Al Homoud I; Eldali A; Altonen B; Handoom BS; Mbekeani JN
    Ophthalmic Genet; 2019 Aug; 40(4):313-322. PubMed ID: 31269850
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term liver disease in methylmalonic and propionic acidemias.
    Imbard A; Garcia Segarra N; Tardieu M; Broué P; Bouchereau J; Pichard S; de Baulny HO; Slama A; Mussini C; Touati G; Danjoux M; Gaignard P; Vogel H; Labarthe F; Schiff M; Benoist JF
    Mol Genet Metab; 2018 Apr; 123(4):433-440. PubMed ID: 29433791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optic nerve atrophy in propionic acidemia.
    Ianchulev T; Kolin T; Moseley K; Sadun A
    Ophthalmology; 2003 Sep; 110(9):1850-4. PubMed ID: 13129889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a signs and symptoms outcome measure for caregivers of patients with methylmalonic acidemia and propionic acidemia (MMAPAQ).
    Sikirica V; Schwartz EJ; Vockley J; Stagni K; Bellenger MA; Banerjee G; Durgam N; Moshkovich O
    Mol Genet Metab; 2024; 143(1-2):108577. PubMed ID: 39303317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review.
    Pillai NR; Stroup BM; Poliner A; Rossetti L; Rawls B; Shayota BJ; Soler-Alfonso C; Tunuguntala HP; Goss J; Craigen W; Scaglia F; Sutton VR; Himes RW; Burrage LC
    Mol Genet Metab; 2019 Dec; 128(4):431-443. PubMed ID: 31757659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of ocular manifestations in cobalamin C and cobalamin A types of methylmalonic acidemia.
    Ku CA; Ng JK; Karr DJ; Reznick L; Harding CO; Weleber RG; Pennesi ME
    Ophthalmic Genet; 2016 Dec; 37(4):404-414. PubMed ID: 26979128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High protein prescription in methylmalonic and propionic acidemia patients and its negative association with long-term outcome.
    Molema F; Haijes HA; Janssen MC; Bosch AM; van Spronsen FJ; Mulder MF; Verhoeven-Duif NM; Jans JJM; van der Ploeg AT; Wagenmakers MA; Rubio-Gozalbo ME; Brouwers MCGJ; de Vries MC; Fuchs S; Langendonk JG; Rizopoulos D; van Hasselt PM; Williams M
    Clin Nutr; 2021 May; 40(5):3622-3630. PubMed ID: 33451859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of propionic and methylmalonic acidemias. Part 1: Complications.
    Haijes HA; Jans JJM; Tas SY; Verhoeven-Duif NM; van Hasselt PM
    J Inherit Metab Dis; 2019 Sep; 42(5):730-744. PubMed ID: 31119747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for drug development in propionic and methylmalonic acidemias.
    Longo N; Sass JO; Jurecka A; Vockley J
    J Inherit Metab Dis; 2022 Mar; 45(2):132-143. PubMed ID: 35038174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of long-term effectiveness of the use of carglumic acid in patients with propionic acidemia (PA) or methylmalonic acidemia (MMA): study protocol for a randomized controlled trial.
    Nashabat M; Obaid A; Al Mutairi F; Saleh M; Elamin M; Ahmed H; Ababneh F; Eyaid W; Alswaid A; Alohali L; Faqeih E; Aljeraisy M; Hussein MA; Alasmari A; Alfadhel M
    BMC Pediatr; 2019 Jun; 19(1):195. PubMed ID: 31196016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding acute metabolic decompensation in propionic and methylmalonic acidemias: a deep metabolic phenotyping approach.
    Haijes HA; Jans JJM; van der Ham M; van Hasselt PM; Verhoeven-Duif NM
    Orphanet J Rare Dis; 2020 Mar; 15(1):68. PubMed ID: 32143654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective evaluation of the Dutch pre-newborn screening cohort for propionic acidemia and isolated methylmalonic acidemia: What to aim, expect, and evaluate from newborn screening?
    Haijes HA; Molema F; Langeveld M; Janssen MC; Bosch AM; van Spronsen F; Mulder MF; Verhoeven-Duif NM; Jans JJM; van der Ploeg AT; Wagenmakers MA; Rubio-Gozalbo ME; Brouwers MCGJ; de Vries MC; Langendonk JG; Williams M; van Hasselt PM
    J Inherit Metab Dis; 2020 May; 43(3):424-437. PubMed ID: 31828787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subacute bilateral visual loss in methylmalonic acidemia.
    Traber G; Baumgartner MR; Schwarz U; Pangalu A; Donath MY; Landau K
    J Neuroophthalmol; 2011 Dec; 31(4):344-6. PubMed ID: 21873889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 21 as a biomarker for long-term complications in organic acidemias.
    Molema F; Jacobs EH; Onkenhout W; Schoonderwoerd GC; Langendonk JG; Williams M
    J Inherit Metab Dis; 2018 Nov; 41(6):1179-1187. PubMed ID: 30159853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular manifestations of cobalamin C type methylmalonic aciduria with homocystinuria.
    Fuchs LR; Robert M; Ingster-Moati I; Couette L; Dufier JL; de Lonlay P; Brodie SE
    J AAPOS; 2012 Aug; 16(4):370-5. PubMed ID: 22929452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for organic acidemias: Lessons learned from methylmalonic and propionic acidemia.
    Chandler RJ; Venditti CP
    J Inherit Metab Dis; 2024 Jan; 47(1):63-79. PubMed ID: 37530705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of organic acidemia in neonates from neonatal intensive care units].
    Xu FL; Fan T; Duan JJ; Chen D
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 May; 14(5):336-9. PubMed ID: 22613102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.